Brief introduction of Shaanxi Momeide Pharmaceutical Co., Ltd.

Xianyang, an ancient city located at the source of traditional Chinese medicine culture in China, was founded in 1995, and it has grown from small to large and from weak to strong in the ebb and flow of the pharmaceutical industry. The pharmaceutical production base of Momede Company is located in Xianyang High-tech Development Zone, with a building area of 1.56 million square meters, covering an area of 65,438+10,000 square meters, and 536 management, scientific research and production personnel. Among them, senior managers account for 10% of the total employees, professional technicians account for 75% of the total employees, and the total assets of the enterprise exceed 200 million yuan.

Guided by the corporate culture concept of "honesty, discipline and enterprising", Shaanxi Momeide Pharmaceutical Company has been rated as "high-tech industry", "Shaanxi pharmaceutical industry demonstration enterprise", "contract-abiding and trustworthy enterprise" and "AAA credit customer" for many years. Wang Baoan, the chairman of the company, was awarded as a model worker in Xianyang in 2007. In 2008, he was awarded "Excellent Builder of Socialism with Chinese characteristics in the Thirty Years of Reform and Opening-up" by the provincial people's government; In the same year, he was awarded the honorary title of "Advanced Individual in New Rural Construction of Private Enterprises in Xianyang".

With the support of the national policy of vigorously developing Chinese medicine industry, Shaanxi Momeide Pharmaceutical Company plans to invest nearly 100 million yuan, make overall design and sub-projects investment, actively expand scientific research and production bases, and realize investment in facilities and equipment of more than 50 million yuan. The enterprise has 9 pharmaceutical dosage forms production lines and passed the national GMP certification. In the process of independent innovation and intellectual property protection, Shaanxi Momede Pharmaceutical Co., Ltd. has completed the combination of more than ten kinds of products such as gynecology, pediatrics, gastroenterology, cardiovascular and cerebrovascular diseases, orthopedics and urology through the combination of independent research and development and cooperative development. The process engineering research and development center established in the company's production base provides strict and efficient quality assurance for the production of various new products; The GMP management system of the enterprise ensures that all products in all aspects of production leave the factory in the company, and the internal control index of the enterprise is greater than or higher than the national standard in the whole process of production, storage and transportation, thus ensuring the safety and effectiveness of the products.